Guaiacoxypropanolamine Derivatives of Capsaicin: A New Family of .beta.-Adrenoceptor Blockers with Intrinsic Cardiotonic Properties

Journal of Medicinal Chemistry
1994.0

Abstract

A series of guaiacoxypropanolamine derivatives of capsaicin was synthesized by replacing the phenolic OH of N-nonanoylvanillamide with epichlorohydrin, followed by cleavaging the obtained epoxide compound with alkylamines. Intravenous injection of these propanolamine derivatives (1 mg/kg) in normotensive Wistar rats induced a transient fall in blood pressure but significantly reduced the heart rate for more than 30 min. These derivatives (10(-8)-10(-6) M) inhibited isoproterenol (10(-10)-10(-5) M)-induced positive chronotropic and inotropic effects in isolated guinea pig atrium. On the other hand, these derivatives (10(-5)-10(-4) M) exhibited a positive cardiotonic effect that is independent of intrinsic sympathomimetic effects. Investigation of the structure-activity relationship of these derivatives revealed that the position of the oxypropanolamine side chain and substituents of the 4-OH position play significant roles in imparting their pharmacological effects. Of the derivatives tested, the most effective one was compound 9. In conclusion, the results obtained from in vitro and in vivo studies suggested that these derivatives and compound 9 may be expected to be beta-adreneoceptor blocking agents with nonadrenergic positive chronotropic and inotropic properties.

Knowledge Graph

Similar Paper

Guaiacoxypropanolamine Derivatives of Capsaicin: A New Family of .beta.-Adrenoceptor Blockers with Intrinsic Cardiotonic Properties
Journal of Medicinal Chemistry 1994.0
Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone
Bioorganic & Medicinal Chemistry 2018.0
.beta.-Adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols
Journal of Medicinal Chemistry 1980.0
Synthesis of a series of compounds related to betaxolol, a new .beta.1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases
Journal of Medicinal Chemistry 1987.0
.beta.-Adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols
Journal of Medicinal Chemistry 1982.0
.beta.-Adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido)alkyl]amino]-2-propanols
Journal of Medicinal Chemistry 1982.0
Ultra-short-acting .beta.-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function
Journal of Medicinal Chemistry 1983.0
o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as .beta.-blocking/diuretic agents
Journal of Medicinal Chemistry 1993.0
Antihypertensive indole derivatives of phenoxypropanolamines with .beta.-adrenergic receptor antagonist and vasodilating activity
Journal of Medicinal Chemistry 1980.0
Conjugates of Catecholamines. 5. Synthesis and β-Adrenergic Activity of N-(Aminoalkyl)norepinephrine Derivatives
Journal of Medicinal Chemistry 1985.0